IBJNews

Indianapolis-based FAST Diagnostics gets funding from BioCrossroads' seed fund

Back to TopCommentsE-mailPrintBookmark and Share
On The Beat Industry News In Brief

Indianapolis-based FAST Diagnostics has received a second round of funding from BioCrossroads’ Indiana Seed Fund.

The $150,000 will help FAST refine its tool to treat acute kidney injury and to prepare for large, preclinical studies.

Previously, the $6 million BioCrossroads fund invested $380,000 toward initial commercialization efforts.

“The lackluster capital market has proven to be a challenge,” said Joe Muldoon, FAST’s CEO.

BioCrossroads CEO David Johnson said FAST has continued to meet key milestones and has successfully built partnerships with other companies and with colleges, including Rose-Hulman Institute of Technology, Indiana University and Purdue University.

FAST has been buoyed by additional funding, including $200,000 from the Purdue Research Foundation and a $1.1 million grant from the National Institutes of Health.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
thisissue1-092914.jpg 092914

Subscribe to IBJ
ADVERTISEMENT